Endothelial cannabinoid CB1 receptor deficiency reduces arterial inflammation and lipid uptake in response to atheroprone shear stress
B. Chen, A. Prabhu, G. Li, A. Kaltenbach, Y. Wang, G. Shakir, L. Natarelli, R. Megens, Y. Jansen, S. Ramanathan, M. Geiger, A. Faussner, M. Hristov, D. Richter, X. Di, , S. Steffens
This paper shows that blocking endothelial CB1 receptors reduces arterial inflammation and lipid uptake under atheroprone shear stress, suggesting potential therapeutic benefits for atherosclerosis.
bioRxiv · May 15, 2024 · PreprintImmunology